Difference between revisions of "CNS carcinoma"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "=Guidelines=" to "=Guidelines= '''Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only.'''") |
(→NCCN) |
||
| Line 25: | Line 25: | ||
==[https://www.nccn.org/ NCCN]== | ==[https://www.nccn.org/ NCCN]== | ||
*[https://www.nccn.org/professionals/physician_gls/pdf/cns.pdf NCCN Guidelines - Central Nervous System Cancers] | *[https://www.nccn.org/professionals/physician_gls/pdf/cns.pdf NCCN Guidelines - Central Nervous System Cancers] | ||
| + | *'''2013:''' Nabors et al. [https://doi.org/10.6004/Jnccn.2013.0132 Central nervous system cancers.] [https://pubmed.ncbi.nlm.nih.gov/24029126/ PubMed] | ||
| + | *'''2011:''' Brem et al. [https://doi.org/10.6004/Jnccn.2011.0036 Central nervous system cancers.] [https://pubmed.ncbi.nlm.nih.gov/21464144/ PubMed] | ||
| + | *'''2008:''' Brem et al. [https://doi.org/10.6004/Jnccn.2008.0037 Central nervous system cancers.] [https://pubmed.ncbi.nlm.nih.gov/18492461/ PubMed] | ||
| + | *'''2005:''' Brem et al. [https://doi.org/10.6004/Jnccn.2005.0038 Central nervous system cancers: Clinical Practice Guidelines in Oncology.] [https://pubmed.ncbi.nlm.nih.gov/16194456/ PubMed] | ||
=All lines of therapy= | =All lines of therapy= | ||
Revision as of 19:51, 29 November 2023
| Section editor | |
|---|---|
 |
Seema Nagpal, MD Stanford University Palo Alto, CA, USA |
This page has regimens and guidelines that are not specific to any one type of cancer. For disease-specific regimens and guidelines, please go to the following pages:
1 regimens on this page
1 variants on this page
|
Guidelines
Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only.
ASCO
- 2022: Schiff et al. Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline PubMed
ASCO/SNO/ASTRO
- 2021: Vogelbaum et al. Treatment for Brain Metastases PubMed
EANO/ESMO
- 2021: Le Rhun et al. EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours PubMed
- 2017: Le Rhun et al. EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours PubMed
NCCN
- NCCN Guidelines - Central Nervous System Cancers
- 2013: Nabors et al. Central nervous system cancers. PubMed
- 2011: Brem et al. Central nervous system cancers. PubMed
- 2008: Brem et al. Central nervous system cancers. PubMed
- 2005: Brem et al. Central nervous system cancers: Clinical Practice Guidelines in Oncology. PubMed
All lines of therapy
Whole brain irradiation
WBRT: Whole-Brain Radiation Therapy
Regimen
| Study | Dates of enrollment | Evidence | Comparator | Comparative Efficacy |
|---|---|---|---|---|
| Knisely et al. 2007 (RTOG 0118) | 2002-2004 | Phase 3 (C) | Thalidomide & WBRT | Did not meet primary endpoint of OS |
References
- RTOG 0118: Knisely JP, Berkey B, Chakravarti A, Yung AW, Curran WJ Jr, Robins HI, Movsas B, Brachman DG, Henderson RH, Mehta MP. A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118). Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):79-86. Epub 2007 Dec 31. link to original article contains dosing details in abstract PubMed NCT00033254